You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia

Article metrics

Article menu

Download PDFPDF

XML
Immune cell therapies and immune cell engineering
Original research
Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia

 

Online download statistics by month:

Online download statistics by month: March 2020 to July 2025

AbstractFullPdf
Mar 2020220220150
Apr 2020349349237
May 202023123148
Jun 202012612634
Jul 2020666525
Aug 2020464724
Sep 2020787824
Oct 2020696933
Nov 2020626216
Dec 2020646411
Jan 2021808021
Feb 2021787718
Mar 202120720723
Apr 2021565621
May 2021575714
Jun 2021525249
Jul 2021565620
Aug 2021424238
Sep 2021474723
Oct 2021494942
Nov 2021616128
Dec 2021575729
Jan 2022767924
Feb 2022424317
Mar 2022525616
Apr 2022555815
May 2022596226
Jun 2022606112
Jul 2022636613
Aug 2022666721
Sep 2022707424
Oct 2022677019
Nov 2022626423
Dec 202228299
Jan 2023505216
Feb 2023666622
Mar 2023676914
Apr 2023464713
May 2023464625
Jun 2023333412
Jul 2023323515
Aug 202323238
Sep 202326275
Oct 202336389
Nov 202326265
Dec 2023808111
Jan 2024202112
Feb 2024303025
Mar 2024414245
Apr 2024363618
May 2024424310
Jun 2024464513
Jul 2024484914
Aug 202430299
Sep 202426278
Oct 202437379
Nov 2024252710
Dec 2024272814
Jan 2025333310
Feb 2025969613
Mar 2025212113
Apr 2025424220
May 2025414125
Jun 202520219
Jul 2025110
Total404640941579